• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.

作者信息

Fields K K, Elfenbein G J, Saleh R A, Zorsky P E, Janssen W E, Perkins J B, Saleh T G, Piazza J T, Kronish L E, Machak M C

机构信息

Department of Internal Medicine, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa.

出版信息

Hematol Oncol. 1992 Jan-Feb;10(1):61-74. doi: 10.1002/hon.2900100111.

DOI:10.1002/hon.2900100111
PMID:1563705
Abstract
摘要

相似文献

1
Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.异环磷酰胺、卡铂和依托泊苷联合用于诱导化疗和大剂量化疗：聚焦于乳腺癌和淋巴瘤。
Hematol Oncol. 1992 Jan-Feb;10(1):61-74. doi: 10.1002/hon.2900100111.
2
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.异环磷酰胺、卡铂、依托泊苷和紫杉醇化疗：一项剂量递增研究。
Semin Oncol. 1996 Jun;23(3 Suppl 6):74-7.
3
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗：含与不含高剂量治疗及干细胞救援的方案
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.
4
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.序贯大剂量异环磷酰胺、卡铂和依托泊苷联合利妥昔单抗治疗复发的霍奇金淋巴瘤和大B细胞非霍奇金淋巴瘤：毒性增加但无进展生存期未改善。
Leuk Lymphoma. 2009 May;50(5):741-8. doi: 10.1080/10428190902853136.
5
Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships.异环磷酰胺/卡铂/依托泊苷化疗用于有或无自体造血干细胞移植的转移性乳腺癌：剂量反应关系评估
Semin Oncol. 1995 Jun;22(3 Suppl 7):5-8.
6
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.
J Clin Oncol. 1992 Nov;10(11):1712-22. doi: 10.1200/JCO.1992.10.11.1712.
7
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
Semin Oncol. 1993 Oct;20(5 Suppl 6):59-66.
8
Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.卡铂、异环磷酰胺、依托泊苷和长春新碱联合非格司亭用于小细胞肺癌患者的剂量强度Ⅰ/Ⅱ期试验
Oncology. 1997 Sep-Oct;54(5):363-70. doi: 10.1159/000227719.
9
Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
Semin Oncol. 1996 Jun;23(3 Suppl 6):42-6.
10
High-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.大剂量异环磷酰胺、卡铂和依托泊苷联合自体干细胞支持治疗。
J Clin Oncol. 1995 Jul;13(7):1826-7. doi: 10.1200/JCO.1995.13.7.1826.

引用本文的文献

1
Carboplatin-liposomes (CPL) in immunodeficient mice: improved antitumor activity for breast carcinomas and stimulation of hematopoiesis.卡铂脂质体（CPL）在免疫缺陷小鼠中的应用：对乳腺癌抗肿瘤活性的改善及造血刺激作用
Med Oncol. 1994;11(3-4):111-9. doi: 10.1007/BF02999858.